COLORECTAL CANCER STAGE I

This adverse event was reported 2095 times

These drugs are most commonly taken by patients reporting COLORECTAL CANCER STAGE I:

# Drug Count
0 RANITIDINE 276
1 RANITIDINE HYDROCHLORIDE 126
2 ADALIMUMAB 2
3 AMBRISENTAN 2
4 ESTRADIOL 2
5 FUROSEMIDE 2
6 HYDROCHLOROTHIAZIDE 2
7 INFLIXIMAB 2
8 RIOCIGUAT 2
9 RIVAROXABAN 2
See all common drugs associated with COLORECTAL CANCER STAGE I

COLORECTAL CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 126 0.0023
1 RANITIDINE 276 0.0014
2 OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE 1 0.0001
3 RIOCIGUAT 2 0.0001
4 IMATINIB MESYLATE 1 0.0000
5 OLMESARTAN MEDOXOMIL 1 0.0000
6 ESTRADIOL 2 0.0000
7 MEPOLIZUMAB 1 0.0000
8 AMBRISENTAN 2 0.0000
9 HYDROCHLOROTHIAZIDE 2 0.0000
See all drugs enriched for association with COLORECTAL CANCER STAGE I

COLORECTAL CANCER STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
2 Thiazide Diuretic [EPC] 3 0.0000
3 Estrogen [EPC] 2 0.0000
4 Endothelin Receptor Antagonist [EPC] 2 0.0000
5 Interleukin-12 Antagonist [EPC] 1 0.0000
6 Interleukin-23 Antagonist [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 2 0.0000
8 Loop Diuretic [EPC] 2 0.0000
9 Vitamin D [EPC] 1 0.0000
See all drug classes enriched for association with COLORECTAL CANCER STAGE I